Technical Analysis for APLS - Apellis Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
B 38.04 -4.11% -1.63
APLS closed down 4.11 percent on Friday, September 29, 2023, on 40 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down

Date Alert Name Type % Chg
Multiple of Ten Bearish Other 0.00%
Inside Day Range Contraction 0.00%
Multiple of Ten Bearish Other -4.11%
Inside Day Range Contraction -4.11%
Lower Bollinger Band Touch Weakness -4.11%
New Downtrend Bearish -2.05%
50 DMA Support Bullish -2.05%
Wide Range Bar Range Expansion -2.05%
Multiple of Ten Bearish Other -2.05%
Lower Bollinger Band Touch Weakness -2.05%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day about 8 hours ago
Lower Bollinger Band Support about 10 hours ago
Fell Below Lower Bollinger Band about 10 hours ago
Down 3% about 10 hours ago
60 Minute Opening Range Breakdown about 11 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Apellis Pharmaceuticals, Inc. Description

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit complement component 3 (C3), the central protein in the complement cascade. The Company is developing APL-2 for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) by subcutaneous injection, which is an injection into the tissue under the skin. It is developing APL-2 for the treatment of geographic atrophy (GA) and intermediate age-related macular degeneration (AMD) by intravitreal injection, which is an injection into the eye. The Company is developing APL-1 for the treatment of chronic obstructive pulmonary disease (COPD) by inhaled administration.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Organ Systems Eye Inflammatory Diseases Macular Degeneration Pulmonary Disease Chronic Obstructive Pulmonary Disease Hemoglobin Autoimmune And Inflammatory Disease Complement System Acquired Hemolytic Anemia Copd Hemoglobinuria Paroxysmal Nocturnal Hemoglobinuria Intravitreal Administration

Is APLS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 94.75
52 Week Low 19.8301
Average Volume 4,700,704
200-Day Moving Average 61.84
50-Day Moving Average 36.42
20-Day Moving Average 43.27
10-Day Moving Average 43.74
Average True Range 3.22
RSI (14) 39.39
ADX 25.64
+DI 18.68
-DI 33.01
Chandelier Exit (Long, 3 ATRs) 41.87
Chandelier Exit (Short, 3 ATRs) 44.73
Upper Bollinger Bands 48.75
Lower Bollinger Band 37.78
Percent B (%b) 0.02
BandWidth 25.36
MACD Line 0.03
MACD Signal Line 0.86
MACD Histogram -0.8315
Fundamentals Value
Market Cap 2.88 Billion
Num Shares 75.6 Million
EPS -3.32
Price-to-Earnings (P/E) Ratio -11.45
Price-to-Sales 4846.49
Price-to-Book 33.50
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 41.78
Resistance 3 (R3) 42.15 41.29 41.15
Resistance 2 (R2) 41.29 40.34 41.10 40.94
Resistance 1 (R1) 39.66 39.75 39.23 39.29 40.74
Pivot Point 38.80 38.80 38.58 38.61 38.80
Support 1 (S1) 37.17 37.85 36.74 36.80 35.34
Support 2 (S2) 36.31 37.26 36.12 35.14
Support 3 (S3) 34.68 36.31 34.93
Support 4 (S4) 34.31